drugset / Trial / NCT00941707

An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis

NCT00941707 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy, tolerability and safety of JNJ-38518168 compared with placebo in adult participants with active rheumatoid arthritis (long time systemic disease of the joints, marked by inflammatory changes in the synovial membranes and bones) despite methotrexate (MTX) therapy.

Timeline

Start
2010-02
Primary completion
2010-11
Completion
2010-11

Outcome

Outcome not reported

Stopped: “Due to a single, unexpected serious event, the trial was stopped.”

Drugs

EvaluationDrugModalityDoseRoute
Subject TOREFORANT Small molecule 100 mg Oral

Indications